Jean Jacques Mention active positions
| Companies | Position | Start | End |
|---|---|---|---|
| OSE IMMUNOTHERAPEUTICS | Corporate Officer/Principal | - | - |
Career history of Jean Jacques Mention
Former positions of Jean Jacques Mention
| Companies | Position | Start | End |
|---|---|---|---|
| GENOWAY | Corporate Officer/Principal | 2018-12-31 | - |
Axenis SAS
 Axenis SAS BiotechnologyHealth Technology Part of genOway SA, Axenis SAS develops gene technology and products. The company is based in Paris, France. Axenis was acquired by genOway SA on September 04, 2018 for $0.23 million. | Corporate Officer/Principal | 2014-12-31 | - |
Statistics
International
| France | 4 |
Operational
| Corporate Officer/Principal | 3 |
Sectoral
| Health Technology | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| GENOWAY | Health Technology |
| OSE IMMUNOTHERAPEUTICS | Health Technology |
| Private companies | 1 |
|---|---|
Axenis SAS
Axenis SAS BiotechnologyHealth Technology Part of genOway SA, Axenis SAS develops gene technology and products. The company is based in Paris, France. Axenis was acquired by genOway SA on September 04, 2018 for $0.23 million. | Health Technology |
- Stock Market
- Insiders
- Jean Jacques Mention
- Experience